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Abstract: Sometimes more than one expert advises the court. They use different notional frameworks in doing so, and may report 
different opinions about the case they examined. In this case, the authors discuss the relation between the use of a serotonin reuptake 
inhibitor (SSRI) and a fatal tragedy in a family where the mother was accused of killing her husband and daughter a few days after 
use of the SSRI. No fewer than seven experts were heard (four behavioral experts, one behavioral toxicologist, one pharmacist and 
one pharmacologist) at the ensuing trial, and various possible diagnoses were dealt with in the experts’ reports and at trial. More 
attention must be paid to the mentally debilitating influence of SSRI medication on certain psychological functions shortly after its 
intake. Although a mono-causal relationship between that influence and the accused’s intention is necessary to exculpate the accused 
from guilt, the authors believe that a singular connection is never happened the case. 
 





The effects of a drug on behavior can be disastrous, 
but as presumed, in only very rare cases is there a 
causal relation between the drug in question and a 
violent act, fortunately.  
As more scientists participate in criminal trials, 
greater clarity about the circumstances or the cause of 
a violent offence does not automatically result. 
Amongst other things, this has to do with the 
interpretation of the facts by various disciplines, each 
with their own professional thought patterns, methods 
and testing procedures. For the court to be able to get 
an overall impression, it must at least be aware of the 
methods of the various expert witnesses and actors 
(such as the public prosecutor, the accused, behavioral 
experts and medical specialists) in order to 
meaningfully integrate the evidence and arrive at a 
legal conclusion or verdict. Here, a case was discussed 
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which several experts were heard in a court 
proceeding, who each reported to the court from their 
own notional framework, and from which the court 
had to arrive at a verdict in relation to the facts and 
opinions offered. 
Oei [1] stated the notional frameworks that the 
various parties use during the trial are different. In his 
opinion, the legal, the behavioral and the judicial 
relationship frameworks were applied. Starting with 
the judicial framework, the following issues are 
relevant: offence, possible disorder and danger of 
re-offending and possible treatment. Note that the 
accused often (erroneously) thinks that there is no 
disorder whatsoever. In those cases, however, it is 
possible to discuss the desired treatment with the 
accused. Also, the accused scores positive points with 
the court if he shows willingness for treatment. In this 
way the accused hopes to escape an unconditional 
prison sentence or court order, and instead, ‘to get off’ 
with a suspended sentence with an added condition of 
DAVID PUBLISHING 
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being treated by an institution or expert appointed by 
the court. Furthermore, if the accused does not have a 
disorder, the court cannot attribute the possible danger 
or re-offending to one. For, without a disorder there 
can be no unaccountability and no exemption of 
culpability. 
The lawyer has a slightly different perspective from 
the accused, as follows: possible offence, possible 
disorder, danger of re-offending if there is a disorder, 
accountability, and meting out of punishment. Also, 
the alleged facts of the offence must first be legally 
proven, assuming they give rise to a punishable 
offence. 
Next, the behavioral expert’s framework takes into 
account the following considerations: possible 
disorder, then the relationship with the possible 
offence, determination of accountability, possible 
danger of re-offending as a result of the disorder, and 
possibilities for treatment. 
In determining an accused’s accountability, the 
following questions must be answered from the 
behavioralist’s perspective: is there a pathological 
disorder at the time the punishable offence was 
committed? If yes, is the causal relationship between 
the disorder and the punishable offence adequately 
plausible? Again, if yes, how should the 
accountability be assessed in the light of the first two 
questions and all circumstances of the case? The 
presence of a disorder contributes to recidivism in the 
behavioral expert’s point of view; however, the 
question of recidivism is only asked if the question 
about a relevant disorder has been answered in the 
affirmative.  
Before Oei’s work, Brouwers, Drost and Oei [2] 
had already concentrated on the question of whether 
medication can have undesired effects, or may even 
give rise to violent behavior. As far as the authors 
know there is no drug that always causes violence in 
everyone who takes it. Moreover, some people are 
always prone to violent behavior when they take a 
certain drug, as is the case for instance with alcohol. 
Furthermore, some drugs sometimes produce a 
temporary change in the psychological condition of 
some people. If during that period something 
happens—a threat, or a provocation, for example—the 
person can respond with violence. Still, one needs a 
possible victim to commit a violent crime. 
To elaborate upon the last point, consider the 
following. A serotonin reuptake inhibitor (SSRI) can 
produce a temporary state of depersonalization. If, 
during that period a man is unexpectedly and suddenly 
dismissed from his employment, he may become so 
angry that he wants to kill his boss. Normally he will 
not do that, but then, in this state of depersonalization 
he goes to the house of his boss and is ready to shoot 
him. The boss is not at home and while the man is on 
his way back the depersonalized state disappears and 
he asks himself, “What am I doing?” It is realistic to 
say that probably in most of the cases there no violent 
act during the temporarily changed condition because 
there was no opportunity, or no possible victim. But 
there can be a causal relation if both circumstances 
exist. By taking the medication a temporary disorder 
may occur, causing the person to behave differently 
than usual, but without that particular drug there is no 
disorder or no offence, nor any danger of re-offending. 
In the end the violent behavior is the result of chance. 
If for instance ten thousand people use that drug, 
perhaps a thousand of them will temporarily 
experience depersonalization, a hundred of them will 
experience a serious life event during the 
depersonalization, and ten of them will want to react 
with violent behavior towards that event, five will 
have a possible victim available as well, and finally, 
one will produce a victim. Different levels of damage 
will result in the one instance, depending on how the 
victim responded to the threat.  
In relation to a real case, which concerns a 
well-considered, instrumental form of violence, the 
question arose whether a drug, in particular, an 
anti-depressant (an SSRI) can cause a temporary 
mental disorder leading to a violent offence. 




To illustrate the different processes as illustrated in 
an actual case report, a search was done in the 
Netherlands’ verdict register. This register is freely 
accessible to the public. Because it is essential to go 
step-by-step in time to ascertain if the perpetrator 
knew, or could have known, what the consequences 
were of taking this kind of medicine the following 
search criteria were used: use of an SSRI during 
violent act, start of SSRI use no longer than four 
weeks (prior to the violent act), the verdict must 
contain enough facts and multidisciplinary 
contributions, and the violent act having occurred as 
recently as possible to complement discussions of 
other, past cases. Applying these criteria, four cases 
were found, but only one case provided sufficient 
facts to formulate the within analysis. 
Also, in order to determine if there is any reason to 
believe that there could be a relationship between 
(recent) use of SSRI and violence the literature on this 
topic was reviewed and summarized. 
3. Results  
3.1 Description of the case 
The woman had been suffering from bouts of 
depression since 1996, for which she was treated with 
medication each time. Specifically, since 2003, she 
had been prescribed the drug paroxetine (an SSRI). 
She also suffered a sub-arachnoid haemorrhage, the 
exact location of which was never determined. In June 
2008 she was in a seriously depressed state once 
more, and on 6 August of that year, she was 
prescribed paroxetine again, 20 milligrams once daily. 
The woman did not fill this prescription. When she 
consulted the physician she had discussed whether she 
needed psychological aid. Her daughter very much 
wished the woman would accept this kind of 
assistance. She had promised her daughter she would 
agree to this kind of treatment, but only after 
discussing it with her own GP, which was the reason 
why she had not yet taken the prescribed drug. On 3 
September 2008, she consulted her own GP, and as in 
the meantime there had been no improvements in her 
depressive complaints, the prescribed dose of 
paroxetine was augmented to 20 mg twice daily. 
Arriving home, she started at once with three tablets 
of paroxetine and also two tablets of oxazepam, for 
unknown reasons. The following day she took two 
more pills of paroxetine, but no more oxazepam. 
The night of 4 and 5 September, after midnight, the 
woman met her daughter at Schiphol Airport, 
Amsterdam. Her daughter asked the woman about her 
discussions with the GP and the woman said that she 
had chosen the drug and not the psychological 
assistance, unlike her earlier promise to her daughter. 
The daughter got very cross with her mother. This 
conflict created a bad atmosphere in the home, and 
after her husband and her daughter had gone off to 
bed, the woman was very shaken and sad. 
She sat on her settee and experienced an 
overwhelming feeling that she did not want to live any 
more. At the same time she felt that she could not 
cause the grief that her suicide would inflict upon her 
husband and daughter, and so she decided to take 
them with her in death. She then made fairly extensive 
preparations of her farewell and subsequently went 
looking in the home for a means by which to kill 
them. She found an axe in the garage. The woman 
struck her husband in the head several times with the 
axe, and then thought, “Two more to go”, meaning 
herself and her daughter. After having killed her 
daughter with the axe as well, she tried to commit 
suicide by running her car into a tree. She had by then 
already called the emergency number (at 4.59 a.m.) 
and announced that she had committed murder. The 
woman was wounded in the collision with the tree and 
was taken to hospital. At 9.05 a.m. (5 September), 
blood samples were taken, which were later analyzed 
by the NFI (Dutch Forensic Institute). In the blood, 
traces (< 10 ng/mL whole blood) of paroxetine were 
found. 
Aspects of Causality: a Verdict Inquiry of a Case with SSRI Use 
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There are plenty of questions concerning this case, 
for instance: what is the function of paroxetine in the 
violent acts? Is it a dominant, monocausal, or 
contributory (facilitating) function? Is the contribution 
of paroxetine dose-dependent? How quickly do 
changes occur? Can a temporary mental disorder be 
caused by it? Are there differences in result where the 
violence is impulsive or instrumental?  
3.2 SSRIs and violence 
By open discussions of cases, such as the one just 
described, attention is drawn to important, hitherto 
unknown side effects of drugs [3]. Whether there is 
indeed a causal relationship between the use of the 
drug and the phenomenon observed cannot be directly 
deduced from this, however. That said, scientifically 
proving causality is not essential: rather, identifying 
the possibility for suicide and violence brings about 
attentiveness after the drug in question has been 
prescribed. Only very rarely do the opinions of the 
various experts contrast. Such contrasts, however, do 
occur in the question of whether anti-depressants in 
general, and SSRIs in particular, may give rise to 
suicide and violence. Reports highlight an additional, 
complicating factor, that is, that especially children 
and young people are susceptible [4-6]. 
Healy, Herxheimer and Menkes [7] described a 
possible relationship between SSRIs and violence. In 
addition, SSRI stories [8] listed over two hundred 
cases in which a relation between murder, suicide and 
an anti-depressant was suggested. Lareb [9] identified 
that, until June 2009, 24 cases were reported to the 
Dutch Side Effects Centre in which the use of an SSRI 
and aggression coincide (8 cases of Paroxetine, 5 
cases of Citalopram, 4 cases of Fluoxetine, 4 cases of 
Fluvoxamine, 2 cases of Escitalopram and 1 case of 
Sertraline). They suggested a possible relation 
between SSRIs and aggression. Europe 
Eudravigilance [10] reported 700 serious cases and 
WHO data also supported the association. Special 
attention should be given to this association, 
considering the nature of the adverse drug reaction 
and the possible consequences. Thus, the relationship 
between SSRIs and violence (suicide, homicide) 
cannot be excluded.  
In spite of these reports the chance of violence 
(suicide, homicide) being brought about by the use of 
anti-depressants must be considered to be extremely 
small [11-14]. But this does not necessarily mean that 
this relationship is negligibly small in individual 
cases. And there is understandable issue as to whether 
the risk is “not demonstrable” and “non-existent”. 
It has not been proved that the use of an SSRI may 
give rise to an aggressive incident, but it is plausible. 
This is in line with knowledge gained by general 
experience, that is, that the use of psychoactive 
substances (the best known example is alcohol) may 
give rise to incidents of aggression. SSRIs are 
psychoactive substances and they affect the nature and 
the intensity of emotional processes (e.g. anger). Thus, 
it is possible that under certain circumstances SSRIs 
contribute to the occurrence of an aggressive incident. 
By this the authors mean that the use of the 
medication plays an important part in the occurrence 
of the incident under prevailing conditions and at that 
particular moment. Without the use of the drug, the 
occurrence of the phenomenon, e.g. aggression, 
outburst of anger, outburst of violence, emotions 
running amuck etc. would have been considerably less 
likely. What is the mechanism that triggers the 
aggression?  
The initial idea was that aggression was the result 
of disinhibiting suicidal impulses: a depressive 
disorder goes together with suicidal desires and plans, 
but also with inhibitions, which stop the suicide from 
taking place. By treatment with anti depressants the 
activity, energy level of the patient improve, before 
improving his mood. Because inhibitions disappear, 
some people commit suicide during the first phase of 
the treatment. The biochemical explanatory model 
pointed to the consequences of various kinds of 
neurotransmission (adrenerg and serotonerg). The 
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adrenerg effect was thought to be especially important 
for the impulse (drive) and the serotonerg for the 
mood. Later this is turned out to be too simple for a 
rendition of the facts. The serotonerg system plays a 
part in mood, that is, fear as well as aggression. Even 
a distinct serotonin-dependent subtype of depression 
has been postulated, in which aggression is the first 
symptom [15]. In other words, SSRIs appear not just 
to influence mood. Also, SSRIs cause mental 
deregulations, such as a withdrawal symptoms, during 
the initial phase of treatment or after the treatment has 
been stopped. Quite soon after starting treatment in 
some people, an increase of fear phenomena like 
increased jitteriness, impulse outbursts, fear of dying 
occur. Such symptoms may also occur after a sudden 
end of the treatment. People might become aggressive 
as a result of this feature of treatment with SSRIs. 
A second possible explanation for the occurrence of 
(auto) aggression after the start of the treatment with 
SSRIs are side effects such as akathisia, which is the 
urge to move about and feelings of unrest, unwellness, 
inner unrest, or depersonalization. There are various 
ideas about the method through which akathisia 
triggers aggression. Loonen and Stahl describe a 
biological mechanism in which akathisia is basically 
an artificial form of being motivated to get moving 
[16]. The patient is uncontrollably provoked into 
executing certain (aggressive) behavior. Another idea 
is that akathisia constitutes a torment to such an extent 
that people in their desperation become (auto) 
aggressive. This side effect is typical for 
anti-psychotic medications, but is a regular feature of 
SSRIs [17-19], for instance, with fluoxetine showing 
an incidence rate of between 10% and 25%. Akathisia 
is also a symptom of a serotonerg syndrome featuring 
mental phenomena such as restricted awareness, 
(auto) aggression, neuromuscular phenomena and 
autonomous instability. 
In an attempt to illuminate the mechanism of 
SSRI-induced aggression, two forms of animal 
aggression are relevant: defense and hunt (or, 
assertive) aggression [20]. Of these two forms of 
aggression there is an example in rodents where 
administering anti-depressants had the opposite effect, 
namely, the inhibition of defensive aggression and the 
promotion of assertive aggression [21]. It is postulated 
that in order to initiate these two forms there is in 
principle an emotional, affective or “hot” form of 
aggression as well as a cognitive, instrumental or 
“cold” one. The emotionally initiated form shows 
strong resemblance to the fear reaction and is 
triggered by the amygdala, or the almond core of the 
brain, where the emotional component (anger) is 
primarily triggered. On the other hand, the cognitively 
which initiated form of aggression results from a 
careful analysis of the circumstances and is both 
initiated and controlled by the prefrontal cortex of the 
brain (or PFC). The emotional component (desire) is 
secondary in this case.  
The situation in man is more complex than for 
instance in the cat [22] or the rat [21] on account of 
mankind’s far greater linguistic skill. In man all 
sensory information can be replaced by language 
symbols and aggression can be expressed entirely in a 
linguistic way. Because of this, and because of the 
wider development of the prefrontal brain, the 
instructiveness of the cognitive control is greater. In 
this explanatory model the inhibition of the emotional 
response and the promotion of the cognitive response 
are functions of a certain area of the brain, the medial 
prefrontal cortex [23]. To put it simply: various parts 
of the brain affect each other’s functioning [24]. 
The complex serotonerg system affects these 
structures. There are connections from the brain stem 
to all of the brain structures that were mentioned 
before. And, in order to achieve its effects, no fewer 
than 14 different types of receptors [25] are used, four 
of which are associated with the regulation of 
aggression. When the system is repeatedly 
over-stimulated, the receptors’ sensitivity adapt and 
change what happens as a result. It is supposed that 
SSRIs stimulate aggression by inhibiting and 
Aspects of Causality: a Verdict Inquiry of a Case with SSRI Use 
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stimulating various brain structures, with three 
different types of responses occurring simultaneously: 
dysphoria (feelings of unease), the facilitation of the 
hot (emotional) aggression response and the 
facilitation of the cold (cognitive, instrumental) 
aggression response. 
To sum up, there are indications that SSRIs may 
have a causal relationship with aggressive violent 
behavior, namely, by reducing inhibitions in a 
depression, by side effects such as akathisia and 
depersonalization, and by inhibiting as well as 
stimulating certain areas of the brain, thus promoting 
the emotional and the cognitive aggression response. 
4. Discussion 
4.1 The importance of the concentration of paroxetine 
According to the court’s verdict in 2008, the locum 
had once again prescribed paroxetine to the woman, in 
a dose of 20 milligrams (1 tablet) once daily, but she 
did not fill the prescription. This was confirmed by the 
fact that the prescription was recovered in the 
woman’s home, and also by the pharmacy’s records, 
which showed that no medication had been delivered 
to the woman between 17 December 2007 and 3 
September 2008.  
In the consultation with her own GP on 3 
September 2008 the dose was augmented because the 
GP had supposed that the 20 milligrams per day had 
not been effective. Had the woman started her 
medication on 6 August 2008, she would have been 
taking one tablet of the drug daily for 4 weeks, and 
there would not have been any improvement after 4 
weeks’ medication. (According to the standard GP 
guideline (Dutch General Practitioner Association, 
depressive disorder, M44, 2003), when insufficiently 
effective, the dose should be doubled after four to six 
weeks). 
The woman later testified that she had taken three 
tablets of paroxetine on 3 September and two more on 
4 September. 
The toxicological analysis by the Dutch Forensic 
Institute (NFI) showed traces of paroxetine in her 
blood and concluded that the concentration was so 
low that it could not have influenced her behavior. But 
later, during the trial, pharmacological experts agreed 
that the conclusion was wrong in several respects. On 
the basis of one single measurement of whole blood, 
taken quite some time after the drug has been 
ingested, it cannot be determined how high the 
concentration was shortly after taking the drug. 
Furthermore, in the use of serotonin reuptake 
inhibitors (occasional) cases are known where normal 
short-term use was followed by an outburst of 
violence. 
If violence, as a side effect of an SSRI, is linked to 
the presence in the blood of a relevant quantity of the 
serotonin reuptake inhibitor [26] then the woman’s 
violent behavior could be explained by the use of the 
drug. It should be added that only in those cases when 
at the time of the actions the accused lacked any 
insight into the scope of her actions, and their possible 
consequences, such a situation could lead to acquittal 
because intent is lacking. Such cases are rare because 
evil intent cannot be proven as in conditional intent 
cases. It must be evident that she did not know and 
could not know that such consequences might result 
after taking the drug. However, usually an accused has 
some insight in the scope of his actions, and legal 
practice shows that in such cases a (lack of) intent 
defense is often unsuccessful.  
Sometimes the intent defense is unsuccessful, 
because an accused’s “own culpability” is taken as the 
starting point in law. Intent is then assumed on the 
basis of culpa in causa. “Own culpability” might be 
assumed if it is determined that the accused has taken 
more medication than was prescribed, and that he also 
is aware, or can be aware, that a higher dose might 
lead to committing violence. 
If, in the case being discussed, the woman took 
three tablets on her own accord, because she thought 
that ‘there was no harm in that’ and also that she has 
not heard or read anywhere that there could be harm in 
Aspects of Causality: a Verdict Inquiry of a Case with SSRI Use 
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doing so, “own culpability” is out of the question. But 
if the woman knew about or was aware of this side 
effect, that is, that violent behavior may occur, then 
ingesting the (3 tablet) dose can be seen as “own 
culpability”, and intent can be assumed. The 
discussion during the trial would then probably be 
whether or not the side effect is a rare one. If the side 
effect hardly ever occurs with users of the drug, it is 
reasonable for the defense to plead that “own 
culpability” is out of the question. When the 
concentration in the blood is of no importance and the 
woman never had a similar reaction in previous 
treatments, taking three tablets instead of the 
prescribed two cannot be held against her in relation 
to the violence against her daughter and her husband 
[27]. Finally, whether the woman’s previous 
sub-arachnoid haemorrhage made her more 
susceptible to an undesired effect of paroxetine is also 
questionable, but in other cases of violence and the 
use of serotonin reuptake inhibitors no descriptions of 
a similar affliction were found. 
4.2 The Importance of a Delusion.  
In this case the violence was disproportionate and 
of an instrumental nature, in which the actions were 
prepared over a period of several hours. This could be 
explained by a state of delusion in which reality is 
distorted. It is well known that in a paranoid 
delusional state a situation is perceived as threatening 
or dangerous when in reality there is no threat or 
danger. The woman’s decision to commit suicide and 
to resort to violence towards her husband and daughter 
was perhaps impulsively colored after the argument 
with her daughter. It is known that negative aspects 
receive more attention during a depression, and in this 
case, the negative aspects may have been 
overemphasized in the argument between mother and 
daughter, causing the woman’s judgment to be 
ultimately impaired. But once her decision was made 
obviously there was nothing that could make her stop.  
No fewer than seven experts were heard (four 
behavioral experts, one behavioral toxicologist, one 
pharmacist and one pharmacologist) and various 
possible diagnoses were dealt with in the reports and 
during the trial: delusion, psychosis, delirium, 
depression, recurrent depression, intoxication, 
personality disorder, depersonalization, restricted 
awareness, lowering of barriers, paradoxical reaction, 
triggering effect, fear, primitive defense and coping 
mechanism, suicidality, tunnel vision, subarachnoid 
hemorrhage, organic brain disease, psycho-toxic 
effect. With so many differing expert opinions, it is 
difficult for the court to find its way through this 
maze, making this review appropriate. Because this 
case concerned a well-considered instrumental form of 
violence, psychopathological conditions that are 
associated with this kind of violence as psychosis 
(delusion) or depersonalization enter the picture. In 
depersonalization, feeling is divorced from cognition 
and apparently businesslike actions are possible [28]. 
Reasons for the occurrence of depersonalization are 
severe stress on account of the argument with her 
daughter, sleep deprivation because of staying up into 
the small hours, and the use of the SSRI.  
The accused’s conviction to kill herself as well as 
her daughter and husband may be qualified as a 
psychotic condition within the definition of Van der 
Waard [29]: a delusion could best be described as a 
shuttered unfalsifiable conviction with which the 
patient feels emotionally related and which is deemed 
implausible by most others because of the 
unshakeable certainty with which it is expressed. In 
the trial the woman testified that she had repeatedly 
struck first her husband and then her daughter 
forcefully in the head with an axe in the early hours of 
the morning, and that this was the only way for her to 
do any justice to herself and her family members. The 
verdict does not refer to the concussion she suffered as 
a result of running into the tree, and she could 
obviously remember everything quite well. 
There can be no question of intent, if a person lacks 
any insight in the scope of the actions and their 
Aspects of Causality: a Verdict Inquiry of a Case with SSRI Use 
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possible consequences, as is the case with when 
someone acts in a state of delusion. The woman’s 
attorney maintained that she could not freely exercise 
her will and that she had been deprived of any insight 
in the scope of her actions and their possible 
consequences because her mental condition at the time 
of her deed was seriously impaired. According to the 
court, however, the experts did not agree on the 
existence of a delusion, psychosis, delirium or similar 
condition. They did agree, though, on a recurring 
depression, but not that it was a psychotic depression. 
The experts did not answer the question whether 
paroxetine can cause a delusion or whether during a 
delusion the use of paroxetine can produce or promote 
violent behavior. 
4.3 The affliction, the drug and the deed 
Separate from the framework, from which the 
various parties to court proceedings approach the 
offence (see the Introduction, above), whether the 
affliction, or the drug, or both play a part should be 
addressed. As such, it should be determined whether 
an accused’s actions take place under the influence of 
paroxetine because it can change certain psychological 
processes. The use of paroxetine may affect 
neurophysiologic functions and normal thought 
patterns. Accordingly, in the case being reviewed the 
woman’s thoughts, that she did ‘not want to inflict the 
grief of her suicide on her husband and daughter and 
that she had to take them along’, could not be tested 
against the social norm: it is not acceptable to kill a 
fellow human being. The woman herself testified that 
she took paroxetine in the days preceding her act, and 
indeed, a low concentration of the drug was found in 
her blood. Even with low concentrations of paroxetine 
(or other serotonin reuptake inhibitors) there are cases 
in which (short term) use was followed by violence 
and suicide during the first week of the treatment. See, 
for instance, the case of Joseph Wesbecker, who, in 
the morning of 14 September 1989 in Kentucky, USA, 
shot twelve people while using a serotonin reuptake 
inhibitor. 
In the case being discussed, the woman had both 
the time and the opportunity to reflect on and to 
account for the consequences of her intended actions. 
It is remarkable that, in the period she was preparing 
her actions, the horrible nature of her intentions did 
not make her change her mind. Apparently she was 
convinced that her actions would spare more grief. 
The question is whether she did not register the 
appalling nature of her intended actions as such 
because of the paroxetine affected certain areas of the 
brain that typically have a corrective effect on such 
violent thoughts. 
There are indications that SSRIs affect 
neurocognitive processes. For instance, Almeide and 
his colleagues [30], found that citalopram (a serotonin 
reuptake inhibitor) had a negative effect with healthy 
men on “contextual processing” tasks. The result was 
a temporary anomaly in being able to discriminate 
between new and familiar objects within 24 h after 
taking an anti-depressant. Similarly Harmer and her 
colleagues [31] found that healthy volunteers, with no 
history of depression, showed a diminished response 
in certain areas of the brain to pictures displaying a 
threat. What made this research special was that the 
time in which the picture was displayed was so short 
that the testee was not aware of the threatening 
content, and that, nevertheless, after the use of 
citalopram the areas of the brain in question responded 
less fiercely than without the use of citalopram. With 
people with a depression and a single dose of 
citalopram, the pictures with scary portrayals were 
perceived less fiercely [32]. 
To sum up, in certain persons with a depression, in 
the first few days of their treatment with an SSRI 
neurocognitive processes may be affected in such a 
way that feedback of intended behavior is diminished, 
the SSRI quite possibly has a contributory effect. 
4.4 Assessing causality  
Another question to consider is whether the 
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different players’ frameworks with which they 
approach the legal proceedings could lead to a 
different result? For example, the accused’s lawyer 
looks at the accused’s action(s) as his starting point. In 
the case being reviewed, the woman’s attorney argued 
that in view of her mental condition the woman should 
be found completely unaccountable and that her 
condition did not fit an assumption of premeditation. 
The court rejected this argument in its deliberations 
because, even if her action(s) were not to be attributed 
to her at all, this does not automatically lead to the 
conclusion that she was unable to act with 
premeditation or that the violent actions were not the 
result of an immediate impulse that caused her to act 
without delay. The circumstances outlined by the 
court showed that the accused had the time and the 
opportunity to consider and to account for the 
consequences of her intended actions. The question, 
though, is whether all of this happened while the 
woman was experiencing a pathological condition? 
In court proceedings, the behavioral expert takes the 
disorder as his starting point. In this case the violence 
is instrumental, and accordingly, syndromes that may 
explain instrumental violence must be demonstrated 
or excluded. Earlier akathisia, depersonalization and 
delusion were mentioned, but depression is also of 
importance as SSRIs may have a causal relationship. 
The effects of SSRIs have been mentioned by 
experts, such as a boosting effect or a barrier- (or 
inhibition-) lowering effect, but these were not 
considered to be likely explanations for a violent 
effect of the kind such as was perpetrated by the 
woman. 
Depending on the experts’ advice to the court, a 
wide range of possibilities may be presented, which 
only enter the picture when a disorder is suspected and 
when that disorder is linked to the facts of the 
accused’s charge.  
When paroxetine has an unknown, recorded, direct 
effect (manifesting in distortions of perception, 
cognitive distortions, depersonalization, akathisia), but 
is not dose-dependent, the woman could have been 
acquitted because intent is lacking. But if the effect 
was turned out to be dose-dependent and she was 
aware or could have been aware of such effects, 
culpability, or culpa in causa, enters the picture: it 
may be an unintended or unpursued effect, but 
nevertheless it is the result of taking more than 
prescribed.  
If, as an element of the disorder, a (temporary) 
delusion exists caused by the SSRI medication, then 
complete unaccountability can be put forward, 
resulting in no criminal disposition. If that is not the 
case, and only the depression contributes to the action, 
the woman could be held only partly accountable. 
Should the chance of re-offending be deemed small, 
detention in a mental hospital remains, as typical 
punishment. A treatment order alone could still be a 
possibility because the court might decide to impose a 
conditional sentence, with the specific stipulation that 
the accused undergo treatment. The woman’s 
preparedness to undergo treatment could be discussed 
in the court. Perhaps, in complex cases such as this, it 
is advisable for the public prosecutor and the defense 
attorney to avail themselves of the opportunity (since 
the introduction of the Act Experts in Criminal Cases) 
to have pre-trial deliberations with the magistrate 
about which additional questions regarding what 
content should be provided with in the report pro 
justice. 
5. Conclusions 
It is extremely difficult to find actual cases in which 
a person, by taking a drug prescribed by his doctor, 
acts in a (lethal) violent manner. When answering the 
question in this case as to whether that possibly 
exempted the woman from guilt, the court concluded 
that her accountability was lessened to a certain 
extent, in agreement with the experts’ conclusions. 
However, the court also found that it had not been 
determined which element was exactly responsible for 
this, and to what extent, and that no circumstance had 
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been deemed likely to exclude culpability completely. 
This verdict is acceptable to the authors, because no 
single factor is monocausally related to the offence. 
However, in their opinion, greater value should be 
attached to a contributory psycho-toxic effect from the 
use of medication (SSRIs) and to the disordered 
judgment and critical thinking that go along with the 
resulting (temporarily) psychopathological condition. 
Finally, the various parties to the proceedings should 
be aware of, and should keep in mind the different 
notional frameworks they use during criminal trials. 
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